Morning report: FTSE falls as traders get back to their desks

The FTSE is lower after a long weekend despite UK factory output rising by the fastest pace in more than six years, albeit from a low level as businesses begin to get back to work. 

Movers and shakers include AstraZeneca (LON:AZN) which has received EU approval for Imfinzi which is to treat late stage lung cancer. And the pharma also announced exceptional results for its drug to treat patients with chronic kidney disease.

CentralNic (LON:CNIC) has delivered record growth in the first half despite the global pandemic. The internet domain specialist reported adjusted earnings of US$15.1mln, that up 64% year-on-year. 

Metal Tiger PLC (LON:MTR) said it has invested around £165,000 for a 0.5% stake in Canyon Resources Limited (ASX:CAY), an Australian-listed firm focused in Cameroon.

Kodal Minerals (LON:KOD) is soaring today after an agreement with Chinese engineering firm Sinohydro to work on the company’s lithium project in southern Mali.

And lastly one company that is zooming across the pond is ZOOM! (NASDAQ:ZM) With its stock surging after a 355% boom in quarterly sales. With 370,200 business customers with at least 10 employees - that’s up more than fivefold from a year ago!

Quick facts: AstraZeneca

Price: 7779 GBX

Market: LSE
Market Cap: £972.03 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Greatland Gold's Gervaise Heddle highlights 'tremendous numbers' from recent...

Greatland Gold's (LON:GGP) Gervaise Heddle speaks to Proactive's Andrew Scott following a December quarterly update from Newcrest Mining (ASX:NCM). He talks through what he describes an 'another great set of results' from drilling at Havieron. He says the numbers are very consistent with the...

45 minutes ago

2 min read